Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
43.5M
-
Shares change
-
+8.41M
-
Total reported value, excl. options
-
$460M
-
Value change
-
+$93.2M
-
Put/Call ratio
-
0.74
-
Number of buys
-
47
-
Number of sells
-
-34
-
Price
-
$10.58
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q1 2014
104 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q1 2014.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.5M shares
of 210M outstanding shares and own 20.74% of the company stock.
Largest 10 shareholders include FMR LLC (8.99M shares), BAKER BROS. ADVISORS LP (5.87M shares), RA CAPITAL MANAGEMENT, LLC (4.35M shares), WELLINGTON MANAGEMENT CO LLP (4.02M shares), D. E. Shaw & Co., Inc. (2.07M shares), VANGUARD GROUP INC (1.78M shares), VHCP Management, LLC (1.74M shares), State Street Corp (1.64M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.58M shares), and Cormorant Asset Management, LLC (1.17M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.